论文信息 - Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study) - 字舞流文

Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)

S. Jagannath | S. Lonial | P. Richardson | D. Reece | N. Raje | J. Supko | E. Terpos | Simon S. Jones | D. Tamang | W. Bensinger | C. Wheeler | N. Bahlis | A. Rosko | R. Markelewicz | J. Valent | I. Sandhu | W. Harb | C. Arce-Lara | C. Cole